Meeting Objectives:
-
- Evaluate the implementation and impact of shared decision-making models in MS care, including the composition of MS care teams and strategies for patient involvement.
- Assess the benefits and clinical evidence supporting B-cell therapies in RMS treatment, including their efficacy and safety data and their place in the treatment landscape.
- Discuss strategies to optimize RMS patient care, focusing on pharmacist-led interventions in treatment monitoring, patient education, and addressing access challenges to improve overall outcomes.
Share This Event